Insight Molecular Diagnostics (IMDX) EPS (Diluted) Growth (1y) (2023 - 2026)
Insight Molecular Diagnostics (IMDX) EPS (Diluted) Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 10.71% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | 59.30% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 17.55% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 58.79% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | -6.55% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | -21.08% |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | -9.61% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | 18.37% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 13.90% |
| 10 | Insight Molecular Diagnostics | 172.94 Mn | 144.01 Mn | 15,000.00 | -25.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.44% |
| Dec 31, 2025 | 70.62% |
| Sep 30, 2025 | 65.56% |
| Jun 30, 2025 | 14.64% |
| Mar 31, 2025 | 77.02% |
| Dec 31, 2024 | -47.83% |
| Sep 30, 2024 | 99.88% |
| Jun 30, 2024 | 99.97% |
| Mar 31, 2024 | -137,585.18% |
| Dec 31, 2023 | -205.74% |
| Sep 30, 2023 | 50.10% |
| Jun 30, 2023 | 27.87% |
| Mar 31, 2023 | 100.04% |